1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
(
- Contribution to journal › Article
- 2021
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
(
- Contribution to journal › Article
- 2019
-
Mark
MPRAscore : robust and non-parametric analysis of massively parallel reporter assays
(
- Contribution to journal › Article
- 2018
-
Mark
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
(
- Contribution to journal › Article
- 2017
-
Mark
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
(
- Contribution to journal › Article
-
Mark
Identification of sequence variants influencing immunoglobulin levels
(
- Contribution to journal › Article
-
Mark
SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression
(
- Contribution to journal › Article
- 2015
-
Mark
Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1.
(
- Contribution to journal › Article
-
Mark
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.
(
- Contribution to journal › Article